Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Overview of the Main Anti-SARS-CoV-2 Vaccines: Mechanism of Action, Efficacy and Safety
Maria Teresa Mascellino, Federica Di Timoteo, Massimiliano De Angelis, et al.
Infection and Drug Resistance (2021) Vol. Volume 14, pp. 3459-3476
Open Access | Times Cited: 242

Showing 1-25 of 242 citing articles:

Emerging concepts of miRNA therapeutics: from cells to clinic
Caroline Diener, Andreas Keller, Eckart Meese
Trends in Genetics (2022) Vol. 38, Iss. 6, pp. 613-626
Open Access | Times Cited: 565
Vaccine Technologies and Platforms for Infectious Diseases: Current Progress, Challenges, and Opportunities
Majed Ghattas, Garima Dwivedi, Marc Lavertu, et al.
Vaccines (2021) Vol. 9, Iss. 12, pp. 1490-1490
Open Access | Times Cited: 125
Trials and Tribulations of MicroRNA Therapeutics
Attila A. Seyhan
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 3, pp. 1469-1469
Open Access | Times Cited: 106
Adenoviral Vector-Based Vaccine Platform for COVID-19: Current Status
Vivek P. Chavda, Rajashri Bezbaruah, Disha Valu, et al.
Vaccines (2023) Vol. 11, Iss. 2, pp. 432-432
Open Access | Times Cited: 56
Persistence in risk and effect of COVID-19 vaccination on long-term health consequences after SARS-CoV-2 infection
Ivan Chun Hang Lam, Ran Zhang, Kenneth K. C. Man, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 32
Vaccination and immunotherapies in neuroimmunological diseases
Alexander Winkelmann, Micha Loebermann, Michael Barnett, et al.
Nature Reviews Neurology (2022) Vol. 18, Iss. 5, pp. 289-306
Open Access | Times Cited: 47
COVID-19 vaccine associated demyelination & its association with MOG antibody
M. Netravathi, Kamakshi Dhamija, Manisha Gupta, et al.
Multiple Sclerosis and Related Disorders (2022) Vol. 60, pp. 103739-103739
Open Access | Times Cited: 44
Is Omicron the end of pandemic or start of a new innings?
Swarnali Das, Sovan Samanta, Jhimli Banerjee, et al.
Travel Medicine and Infectious Disease (2022) Vol. 48, pp. 102332-102332
Open Access | Times Cited: 43
Mechanisms of COVID-19 pathogenesis in diabetes
Chandrakala Aluganti Narasimhulu, Dinender K. Singla
AJP Heart and Circulatory Physiology (2022) Vol. 323, Iss. 3, pp. H403-H420
Open Access | Times Cited: 43
The Impact of Coronavirus Disease 2019 on Viral, Bacterial, and Fungal Respiratory Infections
Ashley Losier, Gayatri Gupta, Mario Caldararo, et al.
Clinics in Chest Medicine (2023) Vol. 44, Iss. 2, pp. 407-423
Open Access | Times Cited: 25
SARS-CoV-2 Omicron spike glycoprotein receptor binding domain exhibits super-binder ability with ACE2 but not convalescent monoclonal antibody
Olaposi Idowu Omotuyi, Olujide O. Olubiyi, Oyekanmi Nash, et al.
Computers in Biology and Medicine (2022) Vol. 142, pp. 105226-105226
Open Access | Times Cited: 36
Immune Response to SARS-CoV-2 Vaccines
Navya Bellamkonda, Upendra P. Lambe, Sonali Sawant, et al.
Biomedicines (2022) Vol. 10, Iss. 7, pp. 1464-1464
Open Access | Times Cited: 33
Oral Lesions Following Anti-SARS-CoV-2 Vaccination: A Systematic Review
Federica Di Spirito, Alessandra Amato, Maria Pia Di Palo, et al.
International Journal of Environmental Research and Public Health (2022) Vol. 19, Iss. 16, pp. 10228-10228
Open Access | Times Cited: 33
COVID-19 Therapeutics: Use, Mechanism of Action, and Toxicity (Vaccines, Monoclonal Antibodies, and Immunotherapeutics)
Michael Chary, Alexander F. Barbuto, Sudeh Izadmehr, et al.
Journal of Medical Toxicology (2023) Vol. 19, Iss. 2, pp. 205-218
Open Access | Times Cited: 19
Microneedle technology for potential SARS-CoV-2 vaccine delivery
Megan McNamee, Shuyi Wong, Owen J. Guy, et al.
Expert Opinion on Drug Delivery (2023) Vol. 20, Iss. 6, pp. 799-814
Open Access | Times Cited: 19
Macrophage cell membrane infused biomimetic liposomes for glioblastoma targeted therapy
Daniel Mendanha, Joao Vieira De Castro, Marta R. Casanova, et al.
Nanomedicine Nanotechnology Biology and Medicine (2023) Vol. 49, pp. 102663-102663
Closed Access | Times Cited: 18
Encephalitis following COVID-19 Vaccination: A Systematic Review
Mariam Abdelhady, Muhammad Ashraf Husain, Yousef Hawas, et al.
Vaccines (2023) Vol. 11, Iss. 3, pp. 576-576
Open Access | Times Cited: 17
Gender Differences in Response to COVID-19 Infection and Vaccination
Kawther Zaher, Fatemah Basingab, Jehan Alrahimi, et al.
Biomedicines (2023) Vol. 11, Iss. 6, pp. 1677-1677
Open Access | Times Cited: 17
Autoimmune inflammatory reactions triggered by the COVID-19 genetic vaccines in terminally differentiated tissues
Panagis Polykretis, Alberto Donzelli, Janci C. Lindsay, et al.
Autoimmunity (2023) Vol. 56, Iss. 1
Open Access | Times Cited: 17
Challenges in Emerging Vaccines and Future Promising Candidates against SARS-CoV-2 Variants
Tanmay Ghildiyal, Nishant Rai, Janhvi Mishra Rawat, et al.
Journal of Immunology Research (2024) Vol. 2024, pp. 1-19
Open Access | Times Cited: 7
Adverse Effects of the COVID-19 Vaccine Reported by Lecturers and Staff of Kabul University of Medical Sciences, Kabul, Afghanistan
Mahmoodullah Azimi, Wazhma Masoom Dehzad, Mohammad Asif Atiq, et al.
Infection and Drug Resistance (2021) Vol. Volume 14, pp. 4077-4083
Open Access | Times Cited: 40
COVID-19 vaccines: their effectiveness against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and its emerging variants
Rashed Noor, Saadia Shareen, A. H. M. Muntasir Billah
Bulletin of the National Research Centre/Bulletin of the National Research Center (2022) Vol. 46, Iss. 1
Open Access | Times Cited: 28
COVID-19 Vaccines, Effectiveness, and Immune Responses
Haneen I. Abufares, Leen Oyoun Alsoud, Mohammad A. Y. Alqudah, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 23, pp. 15415-15415
Open Access | Times Cited: 28
Characteristics of COVID-19 Breakthrough Infections among Vaccinated Individuals and Associated Risk Factors: A Systematic Review
Shilpa Gopinath, Angela Ishak, Naveen Dhawan, et al.
Tropical Medicine and Infectious Disease (2022) Vol. 7, Iss. 5, pp. 81-81
Open Access | Times Cited: 27
SARS-CoV-2 vaccine-associated-tinnitus: A review
Syed Hassan Ahmed, Summaiyya Waseem, Taha Gul Shaikh, et al.
Annals of Medicine and Surgery (2022) Vol. 75
Open Access | Times Cited: 26
Page 1 - Next Page

Scroll to top